Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TIGIT antibody (AA 22-141)

The Mouse Monoclonal anti-TIGIT antibody is suitable to detect TIGIT in samples from Human. It has been validated for IHC and ELISA.
Catalog No. ABIN6938571
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for TIGIT antibody (AA 22-141) (ABIN6938571)

Target

See all TIGIT Antibodies
TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Reactivity

  • 101
  • 36
  • 14
Human

Host

  • 62
  • 47
  • 25
  • 1
  • 1
Mouse

Clonality

  • 96
  • 37
  • 3
Monoclonal

Conjugate

  • 83
  • 11
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
This TIGIT antibody is un-conjugated

Application

  • 53
  • 45
  • 44
  • 32
  • 18
  • 17
  • 12
  • 8
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA

Clone

TIGIT-3106
  • Binding Specificity

    • 38
    • 13
    • 6
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-141

    Purpose

    TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) Antibody

    Specificity

    TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation). It has been demonstrated to be upregulated on T cells in many cancers and is a immuno-oncology target for therapy.

    Cross-Reactivity (Details)

    Human.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 22-141) of human TIGIT protein (exact sequence is proprietary)

    Isotype

    IgG2b, kappa
  • Application Notes

    Known_Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Tonsil or Prostate Carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

    Alternative Name

    TIGIT

    Background

    T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain containing 9 (VSIG9), V-set and transmembrane domain containing 3 (VSTM3), Washington University Cell Adhesion Molecule (WUCAM)

    Human tonsil or prostate carcinoma

    Molecular Weight

    26kDa

    Gene ID

    201633, 421750

    UniProt

    Q495A1

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!